GlassScriptPhysician profile
Michael A Geisinger
NPI 1457314247
$422.81
in general payments reported to CMS, 2019-2025
10 companies · $26.58 in 2025
The $26.58 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $80.67 · 2021: $15.22 · 2022: $56.00 · 2023: $49.93 · 2025: $26.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $166.26 | 2019-2020 | |
| Boston Scientific Corporation | $96.62 | 2019-2022 | |
| Trisalus Life Sciences, INC. | $27.78 | 2023 | Trinav Infusion System |
| Angiodynamics, INC. | $26.58 | 2025 | Alphavac |
| Abbott Laboratories | $24.42 | 2020 | |
| Cardiva Medical, INC. | $22.15 | 2023 | Cardiva Vascade 5f Vcs |
| Terumo Medical Corporation | $21.44 | 2022 | |
| Medtronic, INC. | $15.22 | 2021 | |
| Becton, Dickinson and Company | $15.14 | 2022 | |
| Z-Medica, LLC | $7.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Geisinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.